Keck Medicine of USC is conducting a clinical trial that explores using steam as a potential alternative to surgery or ...

demonstrating its value in cancer diagnosis and treatment. Between 2008 and 2023, its oncology immunophenotyping lab saw the number of requests for flow cytometry increase from 3,000 to 8,500 per ...

Genentech was trying to develop an ADC version of Herceptin (trastuzumab) and Millennium was developing an ADC for the treatment of prostate cancer based ... share price chart (below) is an ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

New Mexico Cancer Center’s cutting-edge approach to diagnosing and treating prostate cancer. With a team of dedicated specialists, their personalized treatment plans focus on the most ...

In an interview with Peers & Perspectives in Oncology, Michael S. Leapman, MD, MHS, discusses the significance of a 10-year ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

TORONTO — Ontario's health minister says the province will now publicly fund a new treatment for advanced-stage prostate ...

Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance practices, such as confirmatory biopsy.

Ontario’s health minister says the province will now publicly fund a new treatment for advanced-stage prostate cancer. Health Canada approved Pluvicto in August 2022, but patients have been ...